Full Schedule

Speaker: Jean-Thomas Issenhuth, PhD (he/him/his) – Sartorius Polyplus

Speaker: Nejc Pavlin, PhD (he/him/his) – Sartorius BIA Separations

Speaker: Tristan Kovačič, MSci – Sartorius BIA Separations

Speaker: Mojca Tajnik Sbaizero, PhD – Sartorius BIA Separations

Chair and Speaker: Simone Aleandri, Dr (he/him/his) – University of Bern

Speaker: Gerhard Rogler, MD, PhD (he/him/his) – University Hospital Zurich

Chair and Speaker: Simone Aleandri, Dr (he/him/his) – University of Bern

Speaker: Ana Beloqui, PhD (she/her/hers) – Université catholique de Louvain

Speaker: Ivan Monteleone, MD – University Rome Tor Vergata

Speaker: Alexandra Teleki, PhD (she/her/hers) – Uppsala University

Speaker: José das Neves, PhD – i3S/University of Porto

Chair and Speaker: Beate Bittner, PhD – F. Hoffmann - La Roche

Chair and Speaker: Simon Matoori, PhD – Université de Montréal

Speaker: Christine Allen, PhD – Intrepid Labs | University of Toronto

Speaker: Hagar Labouta, Ph.D. – University of Toronto

Chair and Speaker: Beate Bittner, PhD – F. Hoffmann - La Roche

Chair and Speaker: Simon Matoori, PhD – Université de Montréal

Speaker: James EM Odonoghue (he/him/his) – IPSOS

Chair and Speaker: Beate Bittner, PhD – F. Hoffmann - La Roche

Chair and Speaker: Simon Matoori, PhD – Université de Montréal

Speaker: Lee Wood, MSc, MCSD (he/him/his) – Medical Human Factors medHF

Speaker: Karsten Cremer, PhD (he/him/his) – Synergy IP Group

Keynote Speaker: Mark Prausnitz, PhD – Georgia Institute of Technology

Moderator: Beate Bittner, PhD – F. Hoffmann - La Roche

Moderator: Simon Matoori, PhD – Université de Montréal

Speaker: Nigel A. Langley, PhD MBA FRSC (he/him/his) – Gaylord Chemical Company

Chair and Speaker: Ali Rajabi-Siahboomi, PhD (he/him/his) – ALi Pharma Solutions LLC

Chair and Speaker: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep

Chair and Speaker: Ali Rajabi-Siahboomi, PhD (he/him/his) – ALi Pharma Solutions LLC

Chair and Speaker: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep

Speaker: Clive G. Wilson, PhD (he/him/his) – Strathclyde Institute Of Pharmacy and BioMedical Sciences

Speaker: Ali Rajabi-Siahboomi, PhD (he/him/his) – ALi Pharma Solutions LLC

Speaker: Randy J. Mrsny, PhD (he/him/his) – University of Bath

Speaker: Vincent Jannin, PhD – Capsugel France SAS / Lonza

Speaker: Alana Stephanie Gouveia, Master of Science (she/her/hers) – Merck Life Science KGaA/ University of Heidelberg

Speaker: Nasim Heshmati, PhD (she/her/hers) – Roquette

Speaker: Pauric Bannigan, PhD (he/him/his) – Intrepid Labs

Speaker: Charles Vesey, MS, RPh – Colorcon

Speaker: Grzegorz Garbacz, PhD – Physiolution

Speaker: Anette Müllertz, PhD (she/her/hers) – University of Copenhagen

Chair and Speaker: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep

Chair and Speaker: Ali Rajabi-Siahboomi, PhD (he/him/his) – ALi Pharma Solutions LLC

Chair and Speaker: Daniel Treffer, PhD (¯\_(ツ)_/¯) – MeltPrep

Chair: Abraham M. Abraham, PhD – Queen's University Belfast

Co-Chair: Jing Yi Estee Lee – Universiti Sains Malaysia

Speaker: Khuloud Al-Jamal, PhD, BSc, FHEA, FRSC – Institute of Pharmaceutical Science, King's College London

Speaker: Stine Ronholt, PhD (she/her/hers) – University of Copenhagen

Speaker: Cory Mahnen – Ashland Specialty Ingredients

Speaker: Patrick Duffy, PhD (he/him/his) – Ashland

Speaker: Seth P. Forster, PhD (he/him/his) – Merck & Co., Inc.

Speaker: Rachel Minrovic – Oakwood Labs

Speaker: Antoine Touzet

Chair and Speaker: Patrick Duffy, PhD (he/him/his) – Ashland

Chair and Speaker: David Kang, PhD – Halozyme Therapeutics

Chair and Speaker: Beate Bittner, PhD – F. Hoffmann - La Roche

Speaker: Advait Badkar, PhD (he/him/his) – Pfizer Inc.

Speaker: Francisco Javier Munoz, PhD, MBA – Roche

Speaker: Sy Gebrekidan, PharmD, PhD (he/him/his) – Johnson & Johnson Innovative Medicine, R&D.

Speaker: Chris Wahl, MD, MBA (he/him/his) – Halozyme Therapeutics

Speaker: Alex Lyness, MSc PhD CEng – SHL Medical

Speaker: Beate Bittner, PhD – F. Hoffmann - La Roche

Speaker: Gerard Bruin (he/him/his) – Pharmacokinetic Sciences / Novartis

Speaker: Brent Rutland, MBA – KORU Medical Systems

Speaker: David Kang, PhD – Halozyme Therapeutics

Speaker: Monica R. Swinney, PhD (she/her/hers) – Gilead Sciences

Chair: Shrirang Karve, PhD – Sanofi

Co-Chair: Marianna Yanez Arteta, PhD (she/her/hers) – AstraZeneca

Speaker: Marianne Ashford, PhD (she/her/hers) – AstraZeneca

Speaker: Maria Teresa Peracchia, PhD – Sanofi

Speaker: Daniel G. Anderson, PhD – Massachusetts Institute of Technology

Speaker: Dan Peer, PhD – Tel Aviv University

Speaker: Ray Schiffelers, PhD (he/him/his) – UMC Utrecht/Nanocell Therapeutics

Speaker: Guarav Sahay, PhD – Oregon State University

Speaker: Sophie Hammer, PhD (she/her/hers) – Evonik Health Care

Speaker: Alexandra Álvarez Fernández – Curapath

Speaker: Philippe Talaga, PhD (he/him/his) – mRNA CoE, Sanofi

Moderator: Ana Cadete, PhD (she/her/hers) – Sanofi

Panelist: Daniel G. Anderson, PhD – Massachusetts Institute of Technology

Panelist: Dan Peer, PhD – Tel Aviv University

Panelist: Guarav Sahay, PhD – Oregon State University

Panelist: Ray Schiffelers, PhD (he/him/his) – UMC Utrecht/Nanocell Therapeutics

Chair: Bryan W. Debiasi, Bryan W. Debiasi, PharmD, PhD Candidate, Pharmaceutical Nanotechnology (he/him/his) – School of Pharmaceutical Sciences of Ribeirão Preto of University of São Paulo - FCFRP/USP

Co-Chair: Flávia A. França (she/her/hers) – Federal University of Minas Gerais

Invited Speaker: Ana Jaklenec, PhD – Massachusetts Institute of Technology

Speaker: Anand Subramony, PhD – Lilly

Speaker: Stijn Hofstraat, PhD (he/him/his) – Nanoworx

Chair: Mariah L. Arral, PhD (she/her/hers) – Tufts University

Co-Chair: Jilian Melamed, PhD (she/they) – University of Pennsylvania

Speaker: Christine Allen, PhD – Intrepid Labs | University of Toronto

Presenter: First Time Attendee Guide

Award Winner: Ruth Schmid, PhD (she/her/hers) – SINTEF Industry

Award Winner: Twan Lammers, PhD, DSc – RWTH Aachen University Clinic

Award Winner: Dan Peer, PhD – Tel Aviv University

Chair: Helena F. Florindo, PhD (she/her/hers) – University of Lisbon

Plenary Speaker: Tanja Weil, Ph.D. – Max Planck Institute for Polymer Research

Chair: Ana Cadete, PhD (she/her/hers) – Sanofi

Co-Chair: Alessio Malfanti

Oral Abstract Speaker: Juliane Nguyen, PhD (she/her/hers) – UNC at Chapel Hill

Oral Abstract Speaker: Pedro Fonte, n/a – Centre for Marine Sciences (CCMAR); University of Algarve

Oral Abstract Speaker: Adem Yildirim, PhD – Oregon Health and Science University

Oral Abstract Speaker: Juan Aparicio-Blanco, PhD (he/him/his) – Complutense University of Madrid

Oral Abstract Speaker: Marie Pinvidic, MSc (she/her/hers) – RWTH Aachen

Oral Abstract Speaker: Giuseppe Longobardi, PhD – Tel Aviv University

Local Chapter Speaker: John Intru Disouza, Sr., Vice President, CRS Indian Chapter (he/him/his) – Bombay Institute of Pharmacy & Research, Dombivli (East)

Oral Abstract Speaker: Ana Baião, PhD (she/her/hers) – i3S - University of Porto

Oral Abstract Speaker: BUNTY SHARMA, PhD (he/him/his) – Queens University Belfast UK

Chair: Khuloud Al-Jamal, PhD, BSc, FHEA, FRSC – Institute of Pharmaceutical Science, King's College London

Co-Chair: Roberta Cillari, PhD (she/her/hers) – Fondazione Umberto Veronesi - University of Palermo

Oral Abstract Speaker: Tomáš Etrych (he/him/his) – Institute of Macromolecular Chemistry, CAS

Oral Abstract Speaker: Alexandre Detappe, PhD (he/him/his) – Gustave Roussy

Oral Abstract Speaker: Thomas X. Neenan, Ph.D (he/him/his) – Nanite Inc.

Oral Abstract Speaker: Jiyuan J. Yang, Ph.D – University of Utah

Oral Abstract Speaker: Constantina Neophytou, Post-Doc Fellow – The Cyprus Institute of Neurology and Genetics

Oral Abstract Speaker: Giovanna Lollo, PhD (she/her/hers) – University of Lyon 1

Oral Abstract Speaker: Marion S. Le Meur (she/her/hers) – IMDEA Nanoscience

Oral Abstract Speaker: Carla Ortuño-Moya – Príncipe Felipe Research Center (CIPF)

Chair: Brie Falkard, PhD – Gilead Sciences

Co-Chair: Gülçin Arslan Azizoğlu, PhD – Georgia Institute of Technology

Oral Abstract Speaker: Jose M. Lagaron, n/a (he/him/his) – CSIC and Bionanopharma

Local Chapter Speaker: Choon Fu Goh, PhD (he/him/his) – Universiti Sains Malaysia

Oral Abstract Speaker: Ivana d'Angelo, PhD (she/her/hers) – DiSTABiF, University of Campania "Luigi Vanvitelli"

Oral Abstract Speaker: Sebastian Hecko, PhD – TU Wien

Oral Abstract Speaker: Joseph Correa – University of Iowa College of Pharmacy

Local Chapter Speaker: Luai R. Khoury – Technion - Israel Institute of Technology

Oral Abstract Speaker: Christian Wells, MSc – Croda

Oral Abstract Speaker: Bárbara Carreira (she/her/hers) – iMed.ULisboa - University of Lisbon

Oral Abstract Speaker: Luigia Serpico, PhD (she/her/hers) – University Medical Center Groningen

Co-Chair: Ashok Renuka Unni, BVSc & AH, MVSc, MBA, PhD (he/him/his) – Amrita Institute of Medical Sciences and Research Center

Oral Abstract Speaker: Jindrich Kopecek, PhD (he/him/his) – University of Utah

Oral Abstract Speaker: Hongjun Li, Sr. (he/him/his) – Zhejiang University

Oral Abstract Speaker: Alessandro Grattoni, Ph.D. (he/him/his) – Houston Methodist Hospital

Oral Abstract Speaker: Elizabeth L. Kelley – Rice University

Oral Abstract Speaker: Xinran Shen, PhD Candidate (she/her/hers) – Sichuan University

Oral Abstract Speaker: Anthony E. Davis, B.S. Biochemistry (he/him/his) – Rice University

Local Chapter Speaker: Sangeun Lee, PhD – Saarland University

Oral Abstract Speaker: Remya Valoor, MS (she/her/hers) – Radboud Univeristy Medical centre

Oral Abstract Speaker: Yurim Kim (she/her/hers) – Korea Institute of Science and Technology

Chair: José das Neves, PhD – i3S/University of Porto

Co-Chair: Ana Beloqui, PhD (she/her/hers) – Université catholique de Louvain

Oral Abstract Speaker: Assaf Zinger – Technion- Israel Institute of Technology

Oral Abstract Speaker: Alexandra Teleki, PhD (she/her/hers) – Uppsala University

Oral Abstract Speaker: Yining Xu, https://pharmacy.scu.edu.cn/info/1063/5342.htm (she/her/hers) – Sichuan University

Oral Abstract Speaker: Marta Rubio-Huertas, MSc (she/her/hers) – Technical University of Denmark

Oral Abstract Speaker: Melitini Koutsoviti, n/a – Novo Nordisk A/S

Local Chapter Speaker: Hao Song, PhD – The University of Queensland

Oral Abstract Speaker: Lucia Lopez Vidal (she/her/hers) – National University of Cordoba

Oral Abstract Speaker: Mingjie Ni (he/him/his) – Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province; Sichuan Engineering Laboratory for Plant-Sourced Drug; West China School of Pharmacy, Sichuan University

Oral Abstract Speaker: Léo Guilbaud, MSc (he/him/his) – UCLouvain

Chair: Simmyung Yook, Ph.D – Sungkyunkwan University

Co-Chair: Daniela Stranges, PhD (she/her/hers) – GlaxoSmithKline Biologicals SA

Speaker: Daniela Stranges, PhD (she/her/hers) – GlaxoSmithKline Biologicals SA

Oral Abstract Speaker: Elias Fattal (he/him/his) – University Paris-Saclay

Oral Abstract Speaker: Jicheng Yu, PhD (he/him/his) – Zhejiang University

Oral Abstract Speaker: Fengju Wang (he/him/his) – SiChuan University

Oral Abstract Speaker: Bram Priem, MD – Trained Therapeutix Discovery

Oral Abstract Speaker: Hsin-Mei Lee, PhD – Academia Sinica

Oral Abstract Speaker: Marwa Sallam, PhD (she/her/hers) – School of Engineering, Brown University, Providence, RI, USA

Oral Abstract Speaker: Dzhangar Dzhumashev, PhD (he/him/his) – University of Geneva